Quick Takeaways
- David E. Wheadon has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,386,219.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of David E. Wheadon
- Location
- Lake Forest, IL
- Summary
- The estimated net worth of David E. Wheadon is at least $2,386,219 dollars as of 28 Jan 2026. David E. Wheadon is the Director of Sotera Health Co and owns shares of Sotera Health Co (SHC) stock worth about $1.63M. David E. Wheadon is the Director of Indivior Pharmaceuticals, Inc. and owns shares of Indivior Pharmaceuticals, Inc. (INDV) stock worth about $730.2K. David E. Wheadon is the Director of Vaxart, Inc. and owns shares of Vaxart, Inc. (VXRT) stock worth about $22K.
- Signature
- /s/ Jordan Saltzberg, Power of Attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David E. Wheadon and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Sotera Health Co ($1,634,089).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David E. Wheadon
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SHC | Sotera Health Co | Director | $1,634,089 | 22 May 2025 | ||
| INDV | Indivior Pharmaceuticals, Inc. | Director | $730,158 | +$62,680 | +9.4% | 26 Jan 2026 |
| VXRT | Vaxart, Inc. | Director | $21,972 | 13 Jun 2025 | ||
| KRTX | Karuna Therapeutics, Inc. | Director | $0 | 18 Mar 2024 | ||
| CCXI | ChemoCentryx, Inc. | Director | 20 Oct 2022 |
Insider Transactions Reported by David E. Wheadon:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.